MCRB earnings
Seres Therapeutics (MCRB) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- MCRB beat EPS estimates in 3 of its last 7 reports.
MCRB earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 4, 2026 | -1.63 | – | – | $593.00K |
| Q2 2026 | Aug 5, 2026 | 0.47 | – | – | $736.00K |
| Q1 2026 | May 5, 2026 | -2.08 | -1.88 | -10.64% | $358.00K |
| Q4 2025 | Mar 12, 2026 | -1.78 | – | – | $438.00K |
| Q3 2025 | Nov 5, 2025 | 0.94 | – | – | $351.00K |
| Q2 2025 | Aug 6, 2025 | -2.27 | -2.72 | 16.54% | $0.00 |
| Q1 2025 | May 7, 2025 | -3.75 | -0.67 | -459.70% | $0.00 |
| Q3 2024 | Nov 13, 2024 | -6.60 | -1.55 | -325.64% | $0.00 |
| Q2 2024 | Aug 13, 2024 | -4.40 | -5.48 | 19.73% | $0.00 |
| Q1 2024 | May 8, 2024 | -5.40 | -6.83 | 20.98% | $0.00 |
| Q4 2023 | Mar 5, 2024 | -6.40 | – | – | -$126.26M |
| Q3 2023 | Nov 2, 2023 | -7.40 | – | – | $310.00K |
| Q2 2023 | Aug 8, 2023 | 7.20 | 10.69 | -32.65% | $126.47M |
| Q1 2023 | May 9, 2023 | -11.40 | – | – | -$522.00K |
| Q4 2022 | Mar 7, 2023 | -0.54 | – | – | $975.00K |
| Q3 2022 | Nov 2, 2022 | -9.80 | – | – | $3.44M |